- Home
- VHI vs CRMD Comparison
VHI vs CRMD Comparison
Compare VHI & CRMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VHI
- CRMD
- Stock Information
- Founded
- VHI 1932
- CRMD 2006
- Country
- VHI United States
- CRMD United States
- Employees
- VHI N/A
- CRMD N/A
- Industry
- VHI Major Chemicals
- CRMD Biotechnology: Pharmaceutical Preparations
- Sector
- VHI Industrials
- CRMD Health Care
- Exchange
- VHI Nasdaq
- CRMD Nasdaq
- Market Cap
- VHI 709.1M
- CRMD 738.4M
- IPO Year
- VHI N/A
- CRMD 2010
- Fundamental
- Price
- VHI $23.77
- CRMD $12.49
- Analyst Decision
- VHI Sell
- CRMD Strong Buy
- Analyst Count
- VHI 1
- CRMD 6
- Target Price
- VHI $20.00
- CRMD $15.67
- AVG Volume (30 Days)
- VHI 21.0K
- CRMD 1.3M
- Earning Date
- VHI 03-06-2025
- CRMD 03-11-2025
- Dividend Yield
- VHI 1.39%
- CRMD N/A
- EPS Growth
- VHI N/A
- CRMD N/A
- EPS
- VHI 3.08
- CRMD N/A
- Revenue
- VHI $2,076,900,000.00
- CRMD $12,262,234.00
- Revenue This Year
- VHI $19.58
- CRMD N/A
- Revenue Next Year
- VHI $11.92
- CRMD $246.41
- P/E Ratio
- VHI $7.47
- CRMD N/A
- Revenue Growth
- VHI 10.99
- CRMD 41184.20
- 52 Week Low
- VHI $12.12
- CRMD $2.89
- 52 Week High
- VHI $41.75
- CRMD $13.85
- Technical
- Relative Strength Index (RSI)
- VHI 52.48
- CRMD 70.88
- Support Level
- VHI $20.40
- CRMD $7.91
- Resistance Level
- VHI $24.55
- CRMD $13.09
- Average True Range (ATR)
- VHI 1.22
- CRMD 0.70
- MACD
- VHI 0.42
- CRMD 0.43
- Stochastic Oscillator
- VHI 81.20
- CRMD 88.68
About VHI Valhi Inc.
Valhi Inc is a holding company that provides chemicals, security products, waste management systems, and real estate development and management through its subsidiaries. It operates its business in three segments, which are Chemicals, Component Products, and Real Estate Management and Development. The company derives maximum revenue from the Chemicals segment. Chemicals Segment is a producer and marketer of value-added titanium dioxide pigments (TiO2). TiO2 is used to impart whiteness, brightness, opacity, and durability to a wide variety of products, including paints, plastics, paper, fibers, and ceramics. Geographically the company operates in the United States, Germany, Canada, Norway, and Belgium, where the majority of revenue comes from the United States.
About CRMD CorMedix Inc.
Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets.